Completed Infection & Immunity Lungs & Breathing

Novel resolution-phase macrophages restore post-inflammation tissue homeostasis

In plain English

AI plain-English summary

A newly discovered type of immune cell actively restores tissues to normal after inflammation has subsided, rather than letting them simply heal on their own. This matters because current treatments for inflammatory diseases focus on stopping inflammation, not on repairing the damage it leaves behind. The researcher has identified a population of macrophages—called resolution-phase cells, or rM—that appear at inflamed sites and release unknown signals that repopulate key immune cells called innate-type lymphocytes. Without these lymphocytes, mice die from subsequent infections. The project aims to identify the specific signals rM cells use and the lymphocyte subtypes responsible for this protection. It will also test whether the same pathways operate in humans. If successful, this fundamental science could explain why some people develop chronic inflammatory diseases or become vulnerable to repeated infections. Understanding these homeostatic pathways might eventually lead to therapies that actively restore tissue health after inflammation, rather than just suppressing immune responses. The work is curiosity-driven at this stage, but similar discoveries about immune resolution have already transformed treatments for arthritis and asthma.

View original technical description
While the objective of acute inflammatory resolution is for cell clearance and pro-inflammatory mediator catabolism, tissues must undergo a final process of restoration of tissue homeostasis. This is not only essential for immune recovery but it restores physiology and prepares tissues to mount appropriately-tempered inflammatory responses to future infections or injuries. On this theme, I identified a new population of macrophages found at sites of resolving inflammation that play a central rol e in this process, called resolution-phase (rM) cells. Through the release of unknown prostanoids and/or chemokines, rM trigger the repopulation of innate-type lymphocytes (rLYM), which are crucial for controlling acute inflammatory responses to subsequent infection/injury and curtailing mortality. Therefore, this application proposes to indentify the rM-derived signals that trigger lymphocyte repopulation and elucidate the lymphocyte subpopulation/s responsible for post-resolution protection. A lso, with access to human resolving inflammatory samples I will investigate whether signaling pathways that restore homeostasis in mice also occur in humans. Thus, I believe that tissues revert back to homeostasis after injury/infection in an active manner controlled by soluble mediators and cellular players inherent to pro-resolution processes. By uncovering these novel pro-homeostatic pathways I hope to advance our understanding of chronic inflammatory diseases and susceptibility to infection.

View the original record at the funder ↗

Researchers

Derek Gilroy (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

How inflammatory resolution shapes long-term tissue immunity
Balancing host-defence and inflammation in wound healing: the role of macrophage-delivered lipid mediators in regulating neutrophil reverse migration and healing.
Understanding macrophage phenotypes in normal and pathological healing: harnessing pro-resolving pathways to drive repair
The interaction between macrophages and fibroblasts in the resolution of inflammation.
Resolving innate inflammatory responses to tissue injury and apoptotic cell clearance to develop novel therapeutic strategies for pulmonary diseases

Original classification

Senior Research Fellowship Basic

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.